American Diabetes Association, Lilly team for annual Victory Over Diabetes event
ATLANTA — The American Diabetes Association, with help from drug maker Eli Lilly, once again is hosting a free communitywide event in Atlanta that’s designed to educate African-Americans on diabetes management.
The annual Victory Over Diabetes event, which will be held on Aug. 20 at the Georgia International Convention Center, will offer educational workshops, health screenings and resources on diabetes. On hand at the event will be actor Anthony Anderson, who is the new spokesman for Lilly’s Fearless African-Americans Connected and Empowered program. Diabetes is said to affect 1-in-7 adults in Georgia, according to the Georgia Department of Community Health.
"Being diagnosed with Type 2 diabetes is life changing, but with the help of a team of medical professionals, I’ve taken control of my disease," Anderson said. "I’m eager to share my story at Victory Over Diabetes and hope to encourage the African-American community in Georgia to feel empowered to take control of their own health."
Click here for more information.
Savient gout drug shows improvements, according to study
EAST BRUNSWICK, N.J. — Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.
Savient said results of phase-3, placebo-controlled trials of Krystexxa (pegloticase) showed that the drug produced significant and sustained reductions in uric acid levels in 42% patients with refractory chronic gout and clinical improvements in a substantial proportion of patients for six months. In addition, 40% of patients received complete resolution of one or more tophi, crystalline urate deposits in the joints, skin and cartilage, compared with 7% of those taking placebo.
The trials were conducted on 212 patients in the United States, Canada and Mexico between June 2006 and October 2007 who had severe gout, allopurinol intolerance or refractoriness, and serum uric acid concentration of 8 mg per deciliter or more. Patients received 12 two-week intravenous infusions with either 8 mg of Krystexxa every two weeks, Krystexxa alternating with placebo or placebo alone.
Innovative Beauty unveils Pixel nail color collection
NEW YORK — Innovative Beauty has unleashed “a little color” in the nail segment with its new Pixel brand of high-shine nail lacquer that hit Ulta stores in early July.
Packaged in mini bottles, the new Pixel brand is aptly named after the single point in a graphic image.
In an effort to bring even greater flexibility and accessibility to nail enamel and to appeal to a wide range of beauty mavens regardless of age, geographic location or season, the collection is comprised of 72 different shades priced at $2.49 each.
Pixel launched chainwide at Ulta during the first week of July, and now Innovative Beauty is looking to expand distribution.